• Complements all around: Alexion to acquire Achillion in $930M deal

    Alexion Pharmaceuticals Inc. is set to acquire Achillion Pharmaceuticals Inc. for about $930 million up front, or $6.30 per share of Achillion common …

    Read More
  • 0 0